Table 1 Baseline characteristics

From: HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition

 

Overall (n = 779)

HPV+ (n = 575)

HPV− (n = 204)

p-value

Demographics

Age, mean (SD)

24.0 (5.2)

23.4 (4.8)

25.5 (5.9)

<0.001

Tenofovir group

50.3 (392)

50.6 (291)

49.5 (101)

0.807

Income < R1000/month

91.2 (634/695)

90.1 (465/516)

94.4 (169/179)

0.092

Married

6.0 (47)

4.0 (23)

11.8 (24)

<0.001

Sexual behavior

Sexual debut median (IQR)

17 (16–19)

17 (16–18)

17 (16–19)

0.746

Lifetime partners

2 (1–3)

2 (1–3)

2 (1–3)

0.694

Sex acts in last 30 days

6 (4–10)

6 (3–10)

6 (4–12)

0.069

Living with regular partner

12.7 (98/772)

10.5 (60/574)

19.2 (38/198)

<0.001

Work away from regular partner

24.0 (185/772)

23.5 (135/574)

25.3 (50/198)

0.003

Knows partner has other partners

21.1 (161/763)

21.1 (119/563)

21.0 (42/200)

0.113

Partner consumes alcohol before sex

29.7 (231)

28.0 (161)

34.3 (70)

0.083

Always used condoms

71.1 (554)

71.1 (409)

71.1 (145)

1.000

Ever had sex for money

1.9 (15)

1.7 (10)

2.5 (5)

0.555

Biological

STI symptoms at baseline

37.2 (290)

38.4 (221)

33.8 (69)

0.273

HSV-2 antibodies

52.3 (407/778)

50.5 (290/574)

57.4 (117/204)

0.103

Positive STI resulta

22.5 (60/267)

25.2 (38/151)

19.0 (22/116)

0.241

Neisseria gonorrhoeae

0.4 (1/267)

0.7 (1/151)

0 (0/116)

1.000

Chlamydia trachomatis

10.9 (29/267)

15.9 (24/151)

4.3 (5/116)

0.003

Trichomonas vaginalis

9.4 (25/267)

8.0 (12/151)

11.2 (13/116)

0.401

Mycoplasma genitalium

3.0 (8/267)

4.0 (6/151)

1.7 (2/116)

0.472

HSV-1 (PCR)

0 (0/267)

0 (0/151)

0 (0/116)

HSV-2 (PCR)

2.3 (6/267)

2.0 (3/151)

2.6 (3/116)

1.000

Haemophilus ducreyi

0 (0/267)

0 (0/151)

0 (0/116)

Treponema pallidum

0 (0/267)

0 (0/151)

0 (0/116)

C. trachomatis LGV strains

0 (0/267)

0 (0/151)

0 (0/116)

  1. HPV+ cervicovaginal HPV DNA detected, HPV- no cervicovaginal HPV DNA detected, SD standard deviation, IQR interquartile range, LGV lymphogranuloma venereum, PCR polymerase chain reaction
  2. aDiagnosis based on the multiplex polymerase chain reaction (PCR)